EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Status Regarding Immunosuppressive Treatment in Patients after Renal Transplantation

Kamila Szumilas iD, Aleksandra Wilk iD, Piotr Wiśniewski, Anna Gimpel, Violetta Dziedziejko iD, Markus Kipp iD, Andrzej Pawlik iD

International Journal of Molecular Sciences · 18.06.2023 · 24 (12) · 10301

DOI: 10.3390/ijms241210301 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.06.2023. Verfasst von Kamila Szumilas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal transplantation is now the best treatment for end-stage renal failure. To avoid rejection and prolong graft function, organ recipients need immunosuppressive therapy. The immunosuppressive drugs used depends on many factors, including time since transplantation (induction or maintenance), aetiology of the disease, and/or condition of the graft. Immunosuppressive treatment needs to be personalised, and hospitals and clinics have differing protocols and preparations depending on experience. Renal transplant recipient maintenance treatment is mostly based on triple-drug therapy containing calcineurin inhibitors, corticosteroids, and antiproliferative drugs. In addition to the desired effect, the use of immunosuppressive drugs carries risks of certain side effects. Therefore, new immunosuppressive drugs and immunosuppressive protocols are being sought that exert fewer side effects, which could maximise efficacy and reduce toxicity and, in this way, reduce both morbidity and mortality, as well as increase opportunities to modify individual immunosuppression for renal recipients of all ages. The aim of the current review is to describe the classes of immunosuppressive drugs and their mode of action, which are divided by induction and maintenance treatment. An additional aspect of the current review is a description of immune system activity modulation by the drugs used in renal transplant recipients. Complications associated with the use of immunosuppressive drugs and other immunosuppressive treatment options used in kidney transplant recipients have also been described.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHumansGraft RejectionImmunosuppressive AgentsImmunosuppression TherapyCalcineurin Inhibitors

Stichwörter der Autor:innen

immunosuppressive drugsimmunosuppressive treatmentrenal transplantation

Substanzen

Immunosuppressive AgentsCalcineurin Inhibitors

Autor:innen und Institutionen

  • Department of Physiology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.
  • Department of Histology and Embryology, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Institute of Anatomy, Rostock University Medical Center, Gertrudenstrasse 9, 18057 Rostock, Germany.

ORCID-Profile: Kamila Szumilas, Aleksandra Wilk, Violetta Dziedziejko, Markus Kipp, Andrzej Pawlik

Zitieren

APA

Szumilas, K., Wilk, A., Wiśniewski, P., Gimpel, A., Dziedziejko, V., Kipp, M., & Pawlik, A. (2023). Current Status Regarding Immunosuppressive Treatment in Patients after Renal Transplantation. International Journal of Molecular Sciences, 24(12), 10301. https://doi.org/10.3390/ijms241210301

Vancouver

Szumilas K, Wilk A, Wiśniewski P, Gimpel A, Dziedziejko V, Kipp M, et al. Current Status Regarding Immunosuppressive Treatment in Patients after Renal Transplantation. International Journal of Molecular Sciences. 2023;24(12):10301. doi:10.3390/ijms241210301

BibTeX
@article{Szumilas2023,
  author = {Szumilas, Kamila and Wilk, Aleksandra and Wiśniewski, Piotr and Gimpel, Anna and Dziedziejko, Violetta and Kipp, Markus and Pawlik, Andrzej},
  title = {Current Status Regarding Immunosuppressive Treatment in Patients after Renal Transplantation},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {12},
  pages = {10301},
  doi = {10.3390/ijms241210301}
}
Kostenlos starten →